This document is an excerpt from the EUR-Lex website
Document 32020L2020
National transposition measures communicated by the Member States concerning:
Richtlinie (EU) 2020/2020 des Rates vom 7. Dezember 2020 zur Änderung der Richtlinie 2006/112/EG in Bezug auf zeitlich befristete Maßnahmen im Zusammenhang mit der Mehrwertsteuer für COVID-19-Impfstoffe und -In-vitro-Diagnostika als Reaktion auf die COVID-19-Pandemie
OJ L 419, 11/12/2020, p. 1–4
(BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
The member states bear sole responsibility for all information on this site provided by them on the transposition of EU law into national law. This does not, however, prejudice the results of the verification by the Commission of the completeness and correctness of the transposition of EU law into national law as formally notified to it by the member states. The collection National transposition measures is updated weekly.
Act amending and supplementing the VAT Act
LOI n° 2020-1721 du 29 décembre 2020 de finances pour 2021
Το Περί Φόρου Προστιθέμενης Αξίας (Τροποποίηση του Έκτου Παραρτήματος) Διάταγμα του 2020.
2021. gada 7. janvāra likums "Grozījumi Pievienotās vērtības nodokļa likumā".
Value Added Tax Act (Eighth Schedule) (Amendment) Regulations, 2021 - VALUE ADDED TAX ACT(CAP. 406)
Art. 3 COVID-19-Steuermaßnahmengesetz (COVID-19-StMG)
Zakon o interventnih ukrepih za pomoč pri omilitvi posledic drugega vala epidemije COVID-19